Participants 65 87 3
cancer-related fatigue
Participants 289 311 3
cancer-related fatigue
Participants 363 390 5
Eligible adults with cancer
Participants 748 802 7
Two hundred ninety patients were accrued to this trial
Participants 1012 1112 3
460-467 in the placebo group and 750 mg/day group versus 480-551 in the 1,000- and 2,000-mg/day arms
